Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient
Shusen Wang, Yuanyuan Du, Boya Zhang, et al.
Cell (2024) Vol. 187, Iss. 22, pp. 6152-6164.e18
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

A rapid chemical reprogramming system to generate human pluripotent stem cells
Yanglu Wang, Fangqi Peng, Zhihan Yang, et al.
Nature Chemical Biology (2025)
Closed Access | Times Cited: 1
The effects of the Wnt/β-catenin signaling pathway on the in vitro differentiation of rat BMSCs into leydig cells
Ping Yan, Yaxiong Guo, Shoaib Muhammad, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
Agnete Kirkeby, Heather Main, Melissa Carpenter
Cell stem cell (2025) Vol. 32, Iss. 1, pp. 10-37
Closed Access
Pre-Type 1 Diabetes in Adolescents and Teens: Screening, Nutritional Interventions, Beta-Cell Preservation, and Psychosocial Impacts
Brody Sundheim, Krish Hirani, M Blaschke, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 383-383
Open Access
Innovative Approaches to Boost Mesenchymal Stem Cells Efficacy in Myocardial Infarction Therapy
Chuanfeng An, Yuan Zhao, Lipeng Guo, et al.
Materials Today Bio (2025) Vol. 31, pp. 101476-101476
Open Access
From bench to bedside: future prospects in stem cell therapy for diabetes
Jiayi Lu, Haojin Cheng, Keyu Chen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
The importance of stem cells in the treatment of type 1 diabetes, type 2 diabetes and diabetes complications
Monika Kamińska, Maria Jasiewicz, Magdalena Miernik-Skrzypczak, et al.
Quality in Sport (2025) Vol. 37, pp. 57420-57420
Open Access
Lineage tracing of pancreatic cells for mechanistic and therapeutic insights
Huan Zhao, Bin Zhou
Trends in Endocrinology and Metabolism (2025)
Open Access
A Cure Within for Type 1 Diabetes: Stem Cell-derived Islet Transplantation
Divyansh Agarwal, Ali Naji
Transplantation (2025)
Closed Access
Advancements and Challenges in Immune Protection Strategies for Islet Transplantation
Xue Wang, Ziyuan Zeng, Dayan Li, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 1
Open Access
Islet organoids: a new hope for islet transplantation in diabetes
Xuemei Yu, C. Liu, Zheng Kuang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Un nouvel espoir pour la thérapie cellulaire du diabète à partir de cellules souches pluripotentes induites
Pierre‐Yves Benhamou
Médecine des Maladies Métaboliques (2025)
Open Access
Therapeutic potential of stem cell‐derived somatic cells to treat metabolic dysfunction‐associated steatotic liver disease and diabetes
Eduardo Hideo Gilglioni, Mayank Bansal, Wadsen St‐Pierre‐Wijckmans, et al.
Obesity Reviews (2025)
Closed Access
Emerging Immunotherapies for Disease Modification of Type 1 Diabetes
Timothy P. Foster, Brittany Bruggeman, Michael J. Haller
Drugs (2025)
Closed Access
iPSC-based Cell Replacement Therapy: From Basic Research to Clinical Application
Jun Takahashi
Cytotherapy (2025)
Closed Access
Stem cells reverse woman’s diabetes — a world first
Smriti Mallapaty
Nature (2024)
Closed Access
Sneaking Islets Into the Liver During Ex-vivo Normothermic Preservation – A Cunning Strategy to Avoid Ischemia and IBMIR
A. M. James Shapiro
Annals of Surgery (2024) Vol. 281, Iss. 2, pp. 185-186
Closed Access
Antigen-specific T cell immunotherapy by in vivo mRNA delivery
Fang‐Yi Su, Jamison C. Siebart, Ching Shen Chan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Autologous stem-cell derived islets — the ultimate frontier in diabetes mellitus?
A. M. James Shapiro
Nature Reviews Endocrinology (2024)
Closed Access
Implantation of autologous induced pluripotent stem cell-derived islets provides long-term insulin independence in a patient with type 1 diabetes
Simon Chu, Peter G. Stock, James M. Gardner
American Journal of Transplantation (2024) Vol. 24, Iss. 12, pp. 2144-2145
Closed Access
Toward a cure for diabetes: iPSC and ESC‐derived islet cell transplantation trials
Junji Fujikura, Takayuki Anazawa, Tarō Toyoda, et al.
Journal of Diabetes Investigation (2024)
Closed Access
Breakthrough in human induced pluripotent stem cell research of the functional cure for type 1 diabetes
Min Xu, Guang Ning
The Innovation (2024) Vol. 6, Iss. 1, pp. 100743-100743
Open Access
Organoids, organs-on-chips, complex in vitro model: Definitions, applications, validation, ethics*
Guillaume Mottet, Alexandre Grassart, Philippe Barthélémy, et al.
Therapies (2024)
Closed Access
Organoïdes, organes sur puce, complex in vitro model: Définitions, applications, validation, éthique*
Guillaume Mottet, Alexandre Grassart, Philippe Barthélémy, et al.
Therapies (2024)
Closed Access
Stem cell islet replacement in type 1 diabetes: From “shelf” to “self”
Eelco J.P. de Koning, Françoise Carlotti
Cell stem cell (2024) Vol. 31, Iss. 12, pp. 1727-1729
Closed Access
Page 1 - Next Page

Scroll to top